Human Xtensions News
17 articles
Middle Eastern Penny Stocks To Watch In July 2025
The article discusses the recent decline in Gulf stock markets due to concerns over U.S. tariffs and weaker oil prices, despite strong corporate earnings in the region. It highlights the potential of penny stocks as affordable entry points for investors seeking growth opportunities. Among the companies mentioned, Dubai Investments PJSC stands out with a market cap of AED12.16 billion, operating in property, investment, manufacturing, contracting, and services sectors. Despite recent revenue growth, the companys future earnings are forecasted to decline by an average of 15.2% annually over the next three years. The article suggests that Dubai Investments PJSC maintains a strong balance sheet but faces challenges with interest payments and future earnings.
Middle Eastern Penny Stocks: Dubai Investments PJSC Leads 3 Promising Picks
Dubai Investments PJSC, a company with a market cap of AED10.33 billion, operates in property, investment, manufacturing, contracting, and services sectors in the UAE and internationally. Despite some challenges, the company has shown robust financial performance, with recent Q1 2025 earnings reporting a net income of AED170.89 million, up from AED119.96 million the previous year. This indicates strong growth momentum. The company benefits from diversified revenue streams and trades at a favorable P/E ratio of 8.2x compared to the AE market average. However, it faces forecasted earnings decline over the next three years and has a weak interest coverage ratio.
Middle Eastern Penny Stocks With Market Caps Under US$3B
Dubai Investments PJSC, a company with a market cap of AED10.08 billion, operates in property, investment, manufacturing, contracting, and services sectors both in the UAE and internationally. The company has shown strong financial performance recently, reporting first-quarter revenue of AED822.91 million and net income of AED170.89 million, indicating growth from the previous year. Despite a robust earnings growth driven by a large one-off gain, forecasts suggest potential earnings decline and dividend sustainability issues due to low free cash flow coverage. The companys debt management appears effective, with a significant decrease in its debt to equity ratio over five years, although interest coverage remains a concern.
Al Dhafra Insurance Company P.S.C Leads These 3 Middle Eastern Penny Stocks To Watch
The article discusses the performance of Middle Eastern penny stocks, highlighting Al Dhafra Insurance Company P.S.C. as a key player in the insurance and reinsurance sectors. Despite being debt-free and having a market cap of AED486 million, the company has experienced a 12.8% annual decline in earnings over the past five years, with net profit margins decreasing to 34.1%. Recent earnings showed a slight decrease in net income to AED38.38 million for 2024. The dividend yield remains attractive at 7.2%, though it is not fully covered by earnings. The article suggests that while Al Dhafra Insurance has potential, its financial performance has been challenging.
Middle Eastern Penny Stocks Under US$100M Market Cap
Hily Holding PJSC, a company managing securities portfolios in the UAE, has demonstrated significant earnings growth, with a 285.4% increase over the past year, surpassing the Industrials industry. The company reported AED 110.99 million in revenue for 2024, up from AED 70.48 million the previous year, and achieved a net income of AED 25.15 million compared to AED 6.53 million last year. Despite the positive growth, the company faces challenges with negative operating cash flow and weak interest coverage. However, its debt levels have improved significantly over five years, and short-term assets cover both short- and long-term liabilities comfortably.
4 שנים אחרי ההנפקה: החברה הרפואית שעשויה להפוך לשלד
יומן אקסטנשנז, חברת רובוטיקה רפואית, חתמה על מזכר הבנות למכירת נכסיה במיליון דולר בלבד, סכום נמוך משמעותית מהשווי שלה בעבר. החברה, שהונפקה ב-2020, חוותה ירידה בהכנסות והסכמים אסטרטגיים בוטלו. המשא ומתן עם חברה סינית נמשך זמן רב, והסכום המוצע ירד משמעותית. החברה עשויה להפוך לשלד אטרקטיבי אם העסקה תצא לפועל. בין בעלי המניות הנוכחיים נמצאים עתליה שמלצר, האחים רייק, ומשקיעים סיניים. בנוסף, חברת לגונה הלת נבחרה לרשימת טכנולוגיות חדשניות של מגזין טיים, ושגרירות בריטניה וקרן דנגור מקימות מיזם לשילוב סטארט-אפים ישראלים במערכת הבריאות הבריטית.
Acquired-by
יומן אקסטנשנס התקשרה בהסכם הפצה עם חברה באבו דאבי
Medical equipment company Yuman Extnshns has entered into a distribution agreement with Atlas Medical, a medical equipment distribution company based in Abu Dhabi. The agreement is for a period of three years from the date of signing, with an option to extend for a year. As part of the agreement, the parties will begin a market evaluation activity in the UAE for a period of about six months. For the evaluation period, Atlas has committed to order a limited number of the companys products worth a total of about $100,000. The agreement also includes confidentiality obligations on the part of Atlas and a commitment to protect the companys intellectual property rights.
PartnersExpand
יומן אקסטנשס מזנקת על רקע הסכם הפצה בלעדי במקסיקו בכ-20 מיליון שקל
Human Xtensions, an Israeli medical device company, has signed an exclusive distribution agreement with Mexicos Smart Medical Solutions. The deal marks Human Xtensions first foray into Latin America. As part of the agreement, Smart Medical Solutions has committed to purchasing approximately 20.5 million shekels worth of Human Xtensions products by the end of 2026. The company also plans to explore partnerships with other distributors in the region.
PartnersExpand
יומן אקסטנשנס מצמצמת פעילות בארה”ב: שואפת לחסוך 31% מההוצאות
יומן אקסטנשן, a company specializing in the development and sale of advanced robotic systems for minimally invasive surgeries, has announced a cost-cutting plan to reduce expenses by 31%. The plan includes reducing operational and marketing expenses, focusing operations in the US market, reducing the companys workforce, and implementing an options plan. The company, which went public in November 2020, employs 68 people and operates in the estimated billion-dollar minimally invasive surgery market. The companys flagship product, HandX, is a robotic system that allows precise control of complex maneuvers in the abdomen. The companys intellectual property is protected by patents, and it is facing challenges in penetrating the US market.
LayoffsExpand
HandX™: The Innovation That's Poised to Change the World of Surgery
Israeli company Human Xtensions is developing advanced technological solutions for the laparoscopic medicine field. Their product, HandXTM, is a smart, digital activation system for laparoscopic control that allows surgeons to perform complex manipulations within the patients body. It is a more affordable and accessible alternative to existing robotic systems in the field. Human Xtensions has received approval from the American FDA and the European CE Mark, and the company went public on the Tel Aviv Stock Exchange in 2020. They see vast potential for their technology in the growing field of laparoscopic medicine and aim to expand their presence in hospitals worldwide.
CustomersPartners
רונן קסטרו ימונה למנכ"ל Human Xtensions - וואלה! כסף
Human Xtensions has appointed Ronen Castro as CEO. Castro is an experienced CEO in the medical device and technology industry. He previously served as CEO of IOPtima Ltd, leading the company through its start-up phase until its acquisition by a Chinese pharmaceutical company for $56 million in 2017. Human Xtensions develops advanced technological devices for surgical procedures, combining the advantages of robotic surgery with the economic benefits of laparoscopic tools. The company has received regulatory approvals and operates in the US, Europe, and Israel. Its founder and CEO is Dr. Tami Frankel.
Management Changes
ההכנסות נעלמו לאחר ההנפקה: הפיאסקו של יומן אקסטנשנס
The financial reports of medical equipment company יומן אקסטנשנס showed a significant increase in losses and a nearly complete disappearance of revenue. The company attributed these challenges to difficulties operating in the European market and the ongoing COVID-19 crisis. Restrictions on movement in Europe and budget prioritization for COVID-19 response by medical institutions created significant obstacles for marketing and sales strategies. יומן אקסטנשנס, which went public in 2020, raised approximately 160 million shekels and had a market value of around 600 million shekels. However, its stock has since declined by over 60%. The companys cash reserves currently stand at approximately 125 million shekels. The main shareholders of the company are Atalia Shamlatzar, Flying Cargo owned by the Raik brothers, Pinnacle, and Mor Investments.
CustomersInvestment
צלילה בהכנסות: דוחות חב' הביומד הזו השאירו את המשקיעים פעורי פה
Yomana Extension, a robotics company, reported a significant drop in revenue for the first half of 2021, leaving investors shocked. The company reported revenue of 1.1 million shekels for the first half of 2021, compared to approximately 20.7 million shekels in the same period last year. The companys loss for the half-year is 27 million shekels, compared to 10.8 million shekels in the same period in 2020. The company hinted in its 2020 annual reports that not everything is going smoothly with its main customer, and that the main customer is not meeting its obligations to the company according to the contract signed between the parties.
Customers
Human Xtensions raised NIS 158 million in its IPO - Israel Electronics News
The article discusses the data collection practices of Techtime, a company that collects anonymous data on visitors for business purposes. The company collects personal data such as email addresses and names through various forms on their website. They use Mailchimp for collecting email addresses and sending marketing materials. Techtime also uses various cloud platforms and third-party providers for operating their website. The article emphasizes that Techtime complies with GDPR requirements and takes measures to protect data and ensure privacy. The key topics discussed in the article include data collection, GDPR compliance, privacy, security, and third-party providers.
CustomersPartners
Human Xtensions assured $50m in TASE IPO
Israeli medical robotics and innovative surgery company Human Xtensions is set to raise $45-50 million in its upcoming IPO on the Tel Aviv Stock Exchange. The company, founded in 2012, has developed smart instruments and handheld surgical systems. Its first product has FDA approval and is in the initial stage of sales. Human Xtensions will be the first med-tech company to hold an IPO on the TASE in nearly a decade. Several other tech companies are also raising funds through IPOs on the TASE.
Public TradingInvestment
Robotic laparoscopic surgery company Human Xtensions mulls TASE IPO at up to $200 million valuation
Israel-based medical device company Human Xtensions Ltd. is considering an IPO on the Tel Aviv Stock Exchange with a valuation of $170 million-$200 million. The company is currently conducting a roadshow among Israeli institutional investors and aims to raise around $50 million. Human Xtensions develops robotic tools for minimally invasive surgery and has raised $40 million to date. The companys product has received regulatory approval in the EU, US, and Israel, and it has a distribution agreement with B. Braun Melsungen AG. Human Xtensions has sold nearly 400 robotic systems in the past year, generating $9 million in revenue.
InvestmentPublic Trading
Human Xtensions Receives FDA Clearance for Its HandX, the First in a Line of Smart Digital Handtop Solutions
Human Xtensions, a startup company that develops handheld digital solutions for minimally invasive surgery, has received FDA 510(k) clearance for HandX. HandX is a light-weight, hand-held device that translates the surgeons hand motions into complex movements inside the patient. The clearance allows Human Xtensions to launch HandX, which is the first product in their modular platform. The company aims to revolutionize minimal invasive surgery with their personalized digital platforms that combine surgical robotics with hand-held solutions.
Investment
